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GLUCOCORTICOIDS-CRH-ACTH-ADRENAL

Reciprocal Regulation of TREK-1 Channels by
Arachidonic Acid and CRH in Mouse Corticotropes
Andy K. Lee, James L. Smart, Marcelo Rubinstein, Malcolm J. Low, and Amy Tse
Department of Pharmacology (A.K.L., A.T.), University of Alberta, Edmonton, Alberta, Canada T6G 2H7;
Department of Molecular and Integrative Physiology and Brehm Diabetes Centre (M.J.L.), University of
Michigan Medical School, Ann Arbor, Michigan 48105; Department of Biology (J.L.S.), George Fox University,
Newberg, Oregon 97132; and Instituto de Investigaciones en Ingenieria Genética y Biologia Molecular (M.R.),
Consejo Nacional de Investigaciones Científicas y Técnicas and Departamento Fisiologia, Biologia Molecular y
Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, 1428 Buenos Aires, Argentina

Arachidonic acid (AA) is generated in the anterior pituitary gland upon stimulation by the ACTH
secretagogue, CRH. Using the patch clamp technique, we examined the action of AA on the excitability
of single pituitary corticotropes obtained from a transgenic mouse strain that expresses the enhanced
green fluorescent protein driven by the proopiomelanocortin promoter. CRH evoked depolarization,
but AA caused hyperpolarization. Under voltage clamp condition, AA caused a rapid inhibition of the
delayed rectifier K⫹ current and then increased a background K⫹ current. Inhibition of AA metabolism
did not prevent the activation of the K⫹ current by AA, suggesting a direct action of AA. The sensitivity
of the AA-activated K⫹ current to fluoxetine, chlorpromazine, extracellular acidification, diphenylbutylpiperidine antipsychotics, and the membrane permeable cAMP analog [8-(4-chlorophenylthio)cAMP] suggest that the current is mediated via TWIK-related K⫹ channel (TREK)-1 channels. Activation
of the CRH receptors that are coupled to the adenylate cyclase pathway suppressed the activation of
TREK-1 current by AA and reversed the AA-mediated hyperpolarization. Intracellular acidification (pH
7.0) increased the basal amplitude of TREK-1 current and resulted in hyperpolarizaton. CRH suppressed
the basal TREK-1 current in cells with intracellular acidification and caused depolarization. Our finding
indicates that TREK-1 channels are important in setting the resting potential in corticotropes. The
opposing actions of CRH and AA on the excitability of corticotropes raise the possibility that AA may
act as a negative feedback regulator to reduce the stimulatory action of CRH and thus prevent excessive
ACTH release during chronic stress.

he endocrine response to stress is primarily controlled
by the hypothalamic-pituitary-adrenal axis. During
stress, neurons in the paraventricular nucleus of the hypothalamus release CRH into the portal circulation. CRH
stimulates the release of the stress hormone, ACTH from
pituitary corticotropes. The CRH-stimulated ACTH secretion is dependent on cytosolic [Ca2⫹] ([Ca2⫹]i) elevation (1). We have shown previously in rat corticotropes
that the stimulation of CRH receptors causes closure of a
background K⫹ current, which in turn leads to membrane
depolarization and activation of voltage-gated Ca2⫹ channels (2). The depolarization-evoked rise in [Ca2⫹]i in turn

T

triggered exocytosis in rat corticotropes (3). Thus, the release of ACTH during CRH stimulation is regulated by the
electrical excitability of the corticotropes. However, the
identity of the CRH-sensitive background K⫹ current in
corticotropes remains elusive. CRH also evokes the release
of arachidonic acid (AA) from rat pituitary cells (4, 5). The
role of AA in ACTH secretion is controversial. At high
concentrations (⬎100 M), AA stimulated basal ACTH
release (4, 6), and inhibition of AA metabolism was reported to either enhance or reduce the CRH-mediated
ACTH release (4 – 6). The complexity of the effects of AA
on ACTH secretion may be partially related to the diverse
Abbreviations: AA, Arachidonic acid; AVP, arginine vasopressin; AZF, adrenal zona fasciculata;
8CPT-cAMP, 8-(4-chlorophenylthio)-cAMP; DPBP, diphenylbutylpiperidine; eGFP, enhanced
green fluorescent protein; ETYA, eicosatetraynoic acid; pHext, pH in the extracellular solution;
pHint, intracellular pH; POMC, proopiomelanocortin; TASK, TWIK-related acid sensing K⫹
channel; TEA, tetraethylammonium; TRAAK, TWIK-related arachidonic acid activated K⫹ channel; TREK, TWIK-related K⫹ channel; TWIK, tandem of pore domains in a weak rectifying K⫹
channel.
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Council on Animal Care. Because the intermediate lobe of the
pituitary gland comprises mostly melanotropes that express
␣-MSH, a POMC gene product, the intermediate lobe of the
pituitary gland in the POMC-eGFP mouse exhibits intense green
fluorescence when viewed under a dissecting microscope. The
anterior lobes of the pituitary glands were dissected from these
mice and dissociated enzymatically as previously described (13).
Dissociated pituitary cells were plated on poly-lysine (0.1 mg/ml;
Sigma-Aldrich Canada, Oakville, Ontario, Canada) coated glass
coverslips and maintained in standard culture condition in
DMEM supplemented with 10% (vol/vol) horse serum, 50 U/ml
penicillin G, and 50 mg/ml streptomycin (all from Sigma) for 1–3
d. Individual corticotropes were identified from the heterogeneous pituitary cell population by their GFP fluorescence (observed with an excitation filter at 400 – 440 nm and an emission
filter at 520 –560 nm).

actions of AA on ion channels. For example, AA was
found to modulate multiple types of voltage-gated K⫹
channels, including the inhibition of the A-type and the
delayed rectifier K⫹ channels (7). In addition, AA was
reported to inhibit some members of the tandem of pore
domains in a weak rectifying K⫹ channel (TWIK)-related
acid-sensing K⫹ channels (TASK) family but activated all
three members [TWIK-related K⫹ channel (TREK)-1,
TREK-2, and TWIK-related arachidonic acid activated
K⫹ channel (TRAAK)] of the TREK (TWIK-related K⫹
channels) family (8). Both the TWIK-related acid-sensing
K⫹ channels and TREK families belong to the tandempore class of K⫹ (K2P) channels, which are important in the
setting of the resting potential in many cell types (8). In
view of the importance of membrane excitability in the
stimulatory action of CRH in rat corticotropes (2), it is
possible that AA may affect corticotropes via its actions on
ion channels and cellular excitability. In the current study,
we employed mouse corticotropes obtained from the proopiomelanocortin (POMC)-enhanced green fluorescent
protein (eGFP) transgenic mice (9 –11). Because the
POMC promoter sequence targets eGFP expression to all
cell types that normally express POMC gene products (e.g.
ACTH, ␤-lipotropin, ␣-MSH, and ␤-endorphin), the
ACTH containing pituitary corticotropes and MSH
containing intermediate lobe melanotropes in this transgenic
mouse model also express GFP fluorescence (12). We
found that AA caused hyperpolarization in GFP-labeled
mouse corticotropes via the activation of TREK-1 channels. Most importantly, CRH acting via the cAMP-dependent pathway inhibited the same channel and caused
depolarization. Inhibition of TREK-1 channels at basal
condition by CRH or fluoxetine resulted in depolarization. In the presence of fluoxetine, the CRH-mediated
depolarization was attenuated. Overall, our findings
indicate that TREK-1 channels have major roles in the
setting of the resting potential in corticotropes, and the
activities of the TREK-1 channels are reciprocally regulated by CRH and AA. The generation of AA in the
corticotropes after CRH stimulation can cause hyperpolarization, which in turn limits the depolarizing actions of CRH. This raises the possibility that AA may act
as an intrinsic negative regulator of ACTH secretion
during chronic stress.

The procedure for the reverse hemolytic plaque assay was
similar to that described previously (2, 14, 15). Briefly, dissociated mouse pituitary cells were suspended in DMEM supplemented with 0.1% (wt/vol) BSA. The pituitary cell suspension
was then mixed with one-third the volume of 12% (vol/vol)
sheep erythrocytes (Colorado Serum Co., Denver, CO) in 0.9%
(wt/vol) NaCl. The erythrocytes were previously conjugated
with Staphylococcus aureus-derived protein A (Sigma), using 0.2
mg/ml CrCl3 as a catalyst. The combined cell suspension was
incubated with a mixture of 10 nM CRH and 100 nM arginine
vasopressin (AVP) and rabbit polyclonal antibodies to rat ACTH
(1:20 dilution; gift from R. J. Kemppainen, Auburn University,
Auburn, AL) for 3 h at 37 C. Plaques (zone of lysed erythrocytes)
were formed by a 30-min exposure to guinea pig complement at
1:50 dilution.

Materials and Methods

Statistical analysis

Cell culture
The generation of the POMC-eGFP transgenic mice was as
described previously (9). To identify mice that express POMCeGFP from the mixed litter, the pituitary gland was removed
from mice killed in accordance with standards of the Canadian

Reverse hemolytic plaque assay

Electrophysiological recording
Membrane potential or current was recorded with the wholecell patch clamp technique with an EPC-9 patch clamp amplifier
(HEKA Electronics, Mahone Bay, Nova Scotia, Canada). The
standard bath solution contained (in mM): 150 NaCl, 10 HEPES,
8 glucose, 2.5 KCl, 2 CaCl2, and 1 MgCl2 (pH 7.4). For most
experiments, the whole-cell pipette solution contained (in mM):
120 K-aspartate, 20 HEPES, 20 KCl, 1 MgCl2, 10 EGTA, 2
Na2ATP, and 0.1 Na4GTP (pH 7.4). Because TREK-1 current
can be increased by intracellular acidification (16), we employed
a whole-pipette solution that was buffered to pH 7.0 in some
experiments. All experiments were performed at room temperature (20 –23 C). A ⫺10 mV, junction potential was corrected
throughout. For the generation of IV plots, individual cell was
voltage clamped at ⫺70 mV and then stepped to different potentials (⫺80 to 40 mV in 10-mV increment) for 200 msec. The
current amplitude at different potentials was averaged from the
last 40 msec of the voltage step.

Origin program 8 (OriginLab Corp., Northampton, MA)
was employed for plotting and statistical procedures. The
two-sample Student’s t test was used in comparisons of values
between two populations of cells. Any difference with P ⬍ 0.05 was
considered statistically significant and was marked with an asterisk
in the figures. All values shown were means ⫾ SEM.
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mouse corticotrope. To examine whether the
depolarization was accompanied by changes
in cell input resistance, we injected small current pulses (5 pA) into the cell. In five cells
examined, CRH depolarized the cell membrane potential from ⫺52 ⫾ 6 to ⫺31 ⫾ 5 mV
(⌬Vm of ⬃21 mV) (Fig. 1C) and increased the
cell input resistance from 1.3 ⫾ 0.3 to 2.4 ⫾
0.8 G⍀ (Fig. 1D). This result suggests that
the CRH-mediated depolarization in mouse
corticotropes may involve the closure of certain background conductance.
AA caused hyperpolarization via the
activation of an outward current
In contrast to the depolarizing action of
CRH, AA caused membrane hyperpolarization. As shown in Fig. 2A, application of AA (5
FIG. 1. GFP-fluorescent mouse corticotropes secreted ACTH and depolarized in
M) resulted in strong hyperpolarization. The
response to CRH stimulation. A, The plaque-forming mouse pituitary cells in the
membrane potential was restored to basal level
reverse hemolytic plaque assay were GFP fluorescent. Brightfield (left panels) and
fluorescent images (right panels) of two mouse pituitary cells that formed plaques. B,
upon the removal of AA. Note that in the conApplication of CRH (20 nM) evoked depolarization in a GFP-fluorescent cell. The
tinued presence of AA, the membrane potential
downward deflections in membrane potential, Vm, were induced by the injection of
reached a plateau (e.g. see figure 8A). The restcurrent pulses (⫺5 pA) to monitor changes in cell input resistance. C, CRH caused
depolarization. The resting Vm (control) and Vm in the presence of CRH (20 nM)
ing potential of mouse corticotropes typically
averaged from five corticotropes. D, The CRH-mediated depolarization was
ranged from ⫺40 to ⫺50 mV. In 53 cells exaccompanied by an increase in cell input resistance. The average cell input resistance
amined, the resting potential was ⫺48 ⫾ 3 mV.
(Rs) before (control) and in CRH (same cells as in C).
Figure 2B shows the average hyperpolarization
caused by 5 or 10 M AA. For cells challenged with 5 M
Results
AA, their mean resting potential before and after AA was
CRH caused membrane depolarization in GFP⫺40 ⫾ 2 and ⫺78 ⫾ 3 mV (n ⫽ 21) (Fig. 2B). For cells
fluorescent mouse corticotropes
challenged with 10 M AA, their mean resting potential
To confirm that the GFP-fluorescent cells isolated from
was hyperpolarized from ⫺45 ⫾ 2 to ⫺82 ⫾ 3 mV (n ⫽
the anterior pituitary gland are corticotropes, we exam4) (Fig. 2B). To examine the ionic mechanisms underlying
ined whether individual GFP-fluorescent cells secrete
the AA-mediated hyperpolarization, we voltage-clamped
ACTH when challenged with CRH and AVP. To measure
individual corticotropes at ⫺70 mV and applied voltage
ACTH secretion from single cells, we employed the reverse
steps (200 msec in duration) to different potentials
hemolytic plaque assay using a polyclonal antibody to rat
(10-mV increment) during the time course of the applicaACTH. Figure 1A shows that individual GFP-fluorescent
mouse pituitary cells formed plaques (a zone of lysed tion of AA. An example of this experiment is shown in Fig.
erythrocytes), indicating that ACTH was released from 3. In control condition (before AA application), outward
the GFP-fluorescent cells. In 49 GFP-fluorescent cells ex- currents that resembled the delayed rectifier could be
amined, approximately 73% of the cells formed plaques, evoked at potentials more than or equal to ⫺20 mV (Fig.
suggesting that upon stimulation, most of the GFP-fluo- 3Ai). Application of AA (10 M) resulted in a gradual
rescent cells can secrete sufficient amount of ACTH that is increase in the holding current at ⫺70 mV (Fig. 3B). About
detectable with the reverse hemolytic plaque assay. For the 2 min after the beginning of AA perfusion, the amplitude
rest of this study, we identified individual corticotropes of the delayed rectifier-like current (activated at potentials
from POMC-eGFP transgenic mice based on their GFP ⱖ⫺20 mV) was reduced, and there was an acceleration in
fluorescence. Using the whole-cell patch technique, we the decay of this voltage-activated current (Fig. 3Aii). Subexamined whether CRH affected the membrane poten- sequently (⬃5 min after the onset of AA perfusion), AA
tial. For the majority of the experiments described here completely suppressed the delayed rectifier-like current
(except for figure 8, C and D), the whole-cell pipette and activated an outward current that exhibited little time
solution was buffered to pH 7.4. Figure 1B shows that dependence during the voltage step (Fig. 3Aiii). The reCRH evoked depolarization in a GFP-fluorescent moval of AA eliminated the time-independent outward
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FIG. 2. AA caused hyperpolarization in corticotropes. A,
Representative example of the changes in membrane potential (Vm) of
a corticotrope when exposed to AA (5 M). B, Mean hyperpolarization
evoked by 5 or 10 M AA. The resting Vm before (control) and in the
presence of AA from the same group of cells were shown.

current (Fig. 3B) but failed to reverse the effects of AA on
the delayed rectifier-like current (Fig. 3Aiv). As shown in
Fig. 3C, AA initially suppressed the outward current
evoked at potentials more than or equal to ⫺20 mV (Fig.
3Cii) but subsequently activated a time-invariant outward
current at all potentials examined (Fig. 3Ciii). The removal of AA reversed the activation of the time-invariant
outward current but not the reduction in the amplitude or
the acceleration in the decay kinetic of the delayed rectifier-like current (Fig. 3Civ). Because a change in the current level near the resting potential can strongly affect
cellular excitability, we examined the change in current
level by AA at ⫺40 mV (near the mean resting potential of
corticotropes) (Fig. 2B). In 53 cells examined, the mean
membrane current at ⫺40 mV before the application of
AA (control condition) was ⫺1.5 ⫾ 0.7 pA, and this value
increased to 102.6 ⫾ 9.8 pA in the presence of 10 M AA.
For cells challenged with 5 M AA, the increase in membrane current at ⫺40 mV was approximately 3-fold
smaller (30 ⫾ 6 pA; n ⫽ 26), suggesting that the effect of
AA on current activation is concentration dependent. Because the current response was more robust in 10 M AA,
we employed 10 M AA in all subsequent experiments.
The AA-activated current did not require AA
metabolism and was carried primarily by Kⴙ
The result in Fig. 3 suggests that the initial effect of AA was
a suppression of the delayed rectifier. Consistent with this

Endocrinology, May 2011, 152(5):1901–1910

notion, in the presence of tetraethylammonium (TEA)
(an inhibitor of the delayed rectifier), only the enhancing effect of AA on the time-invariant outward current
was observed (Fig. 4). As shown in Fig. 4A, application
of TEA eliminated most of the delayed rectifier-like current evoked at potentials more than or equal to ⫺20
mV. In the continued presence of TEA, AA activated an
outward current at potentials more than ⫺80 mV (Fig.
4B), and this current exhibited little time dependence
during the individual voltage step (Fig. 4A). Because AA
is metabolized in cells into a variety of eicosanoid products, we tested whether the effect of AA on the outward
current requires AA metabolism. We examined whether
the actions of AA can be prevented by eicosatetraynoic
acid (ETYA), a nonmetabolizable analog of AA that is a
blocker of lipoxygenase, cycloxygenase, and P450 pathways for AA metabolism (17). As shown in the example in
Fig. 4C, application of ETYA (30 M) partially reduced
the current evoked at potentials more than 0 mV, suggesting that ETYA partially mimicked the inhibitory action of
AA on the delayed rectifier. However, in the continued
presence of ETYA, AA (10 M) could still enhance the
time-invariant outward current at all potentials. In the
presence of extracellular ETYA (30 M), the mean increase in outward current at ⫺40 mV by AA (10 M) was
81.2 ⫾ 29.4 pA (n ⫽ 3). In separate experiments, we included ETYA (30 M) in the whole-cell pipette solution.
Under this condition, exogenous AA (10 M) could still
activate an outward current, and the mean increase in
current at ⫺40 mV was 104.7 ⫾ 35.0 pA (n ⫽ 4). These
values are similar to the AA-mediated enhancement of
current described above in control cells (102.6 ⫾ 9.8 pA;
n ⫽ 53). Thus, AA metabolism is not essential for the
activation of outward current by AA. To examine whether
the AA-activated current is a K⫹ current, we voltageclamped individual corticotropes at ⫺70 mV in an extracellular solution containing 9, 19, 36, or 87 mM [K⫹]. Voltage
steps (200 msec in duration) were then applied to different
potentials (10-mV increment) before and after the application of AA (10 M). Because AA inhibited the delayed rectifier current, the difference between the current evoked in
AA and the control (before AA application) comprised primarily the AA-activated current. Figure 5A shows examples
of IV plot of the AA-activated current when cells were bathed
in different extracellular [K⫹]. Note that the reversal potential of the AA-activated current shifted toward more positive
potentials with increasing extracellular [K⫹]. Figure 5B summarizes the reversal potential of the AA-activated current
obtained from various cells in the presence of the four
different extracellular [K⫹]. The slope of the linear regression is 45 mV (cf. 57 mV expected for K⫹), suggesting that
the AA-mediated current is carried primarily by K⫹.
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oxetine and chlorpromazine suggests
that the AA response in corticotropes involves primarily TREK-1 or TREK-2 but
not TRAAK channels. Consistent with
this, Fig. 6C shows that ruthenium red
(10 M), which was reported to inhibit
approximately 80% of the TRAAK
channels (21), had only a minor effect
(33 ⫾ 12%; n ⫽ 8) on the AA-mediated
current in corticotropes (Fig. 6E). Extracellular acidification was reported to inhibit TREK-1 channels but enhance
TREK-2 channels (22). To further distinguish between the involvement of TREK-1
and TREK-2 channels, we lowered the pH
in the extracellular solution (pHext) from
7.4 to 6.4. Figure 6D shows that extracellular acidification caused a partial inhibition of the AA-mediated current. In
eight cells examined, extracellular acidiFIG. 3. Dual actions of AA on membrane current. A, Current traces evoked from voltage steps
(200 msec) to ⫺40, ⫺20, 0, and 20 mV from a holding potential of ⫺70 mV in control condition
fication reduced the AA-mediated cur(i), in the presence of 10 M AA (ii and iii), and after AA removal (iv). At approximately 2 min after
rent at ⫺40 mV by 44 ⫾ 6% (Fig. 6E).
starting the perfusion of AA, there was a reduction and a change in the decay kinetics of the
Thus, the pharmacological profile of the
delayed rectifier-like current evoked at potentials more than or equal to ⫺20 mV (ii). After
approximately 5 min of perfusion, AA increased an outward current that exhibited little time
AA-activated K⫹ current in corticotropes
dependence during the voltage step (iii). The increase in the time-invariant outward current (but
resembles that of TREK-1 channels. The
not the inhibition of the delayed rectifier-like current) was reversed upon the removal of AA (iv). B,
diphenylbutylpiperidine (DPBP) antipsyChanges in the holding current at ⫺70 mV during AA application. Same cell as in A. At the
different times indicated (i–iv), the cell was voltage stepped to different potentials (⫺80 to 40 mV
chotics, such as penfluridol and pimozin 10-mV increment). C, IV plots at different time course of AA application. The current at
ide, have been reported to be highly podifferent potentials was measured from the mean of the last 40 msec of the voltage step (same
tent inhibitors of the TREK-1 channels
cell as in A and B). Note that the delayed rectifier-like outward current evoked at potentials more
that are basally expressed (i.e. in the abpositive than ⫺20 mV was initially suppressed by AA (ii). Subsequently, AA enhanced the timeinvariant outward current (iii) at all potentials examined.
sence AA) in bovine adrenal zona fasciculata (AZF) cells (23, 24). Figure 6F shows
The AA-mediated current was due to activation of
that penfluridol at 2 and 10 M suppressed the current acTREK-1 channels
tivated by 10 M AA in mouse corticotropes by 30 ⫾ 5% (n ⫽
Because AA was reported to activate the TREK family of
6) and 88 ⫾ 4% (n ⫽ 6), respectively. A similar response was
K⫹ channels (8), we examined the involvement of the TREK
obtained with pimozide (Fig. 6F); pimozide at 2 and 10 M
and TRAAK channels using pharmacological blockers. We
reduced the current activated by 10 M AA by 45 ⫾ 10%
first tested the antidepressant, fluoxetine, which was re(n ⫽ 5) and 86 ⫾ 1% (n ⫽ 3), respectively. Interestingly,
ported to be a potent inhibitor of human TREK-1 channels
when the concentration of AA was lowered to 2 M, pimo(18, 19). As shown in the example in Fig. 6A, application of
zide at 2 M reduced the AA-mediated current by 82 ⫾ 6%
fluoxetine (50 M) in the continued presence of AA (10 M)
(n ⫽ 3) (Fig. 6F). This raises the possibility that the potency
reduced the outward current over a wide range of potentials.
of DPBP in suppressing TREK-1 channels may be related to
In six cells examined, the mean reduction of the AA-mediated
the concentration of AA employed to activate the channels.
current by fluoxetine (50 M) at ⫺40 mV was 82 ⫾ 7% (Fig.
6E). We found that the AA-mediated current could also be
reduced by the antipsychotic drug, chlorpromazine, which The AA-activated TREK current was negatively
was shown to inhibit both human TREK-1 and TREK-2 regulated by cAMP and CRH
The TREK, but not TRAAK, channels are sensitive to
channels but not TRAAK channels (20). Figure 6B shows
that application of chlorpromazine (10 M) in the continued cAMP (16). Consistent with the activation of TREK-1 chanpresence of AA suppressed the current at all potentials ex- nels by AA, we found that the membrane permeable cAMP
amined. On average, chlorpromazine (10 M) reduced the analog,8-(4-chlorophenylthio)-cAMP(8CPT-cAMP),strongly
AA-mediated current at ⫺40 mV by 57 ⫾ 7% (n ⫽ 6) (Fig. reduced the AA-mediated outward current in cortico6E). The sensitivity of the AA-mediated K⫹ current to flu- tropes. Figure 7A shows that the increase in outward cur-
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cotropes under basal condition (without
AA) depolarized the cells by 23 ⫾ 3 mV
(n ⫽ 23) (Fig. 8B), similar to the depolarization evoked by CRH (⬃21 mV)
(Fig. 1C). In the presence of fluoxetine,
the CRH-evoked depolarization (⌬Vm ⫽
11 ⫾ 2 mV; n ⫽ 10) (Fig. 8B) was significantly smaller (P ⫽ 0.04) than that
evoked by CRH in control cells (⌬Vm ⫽
21 ⫾ 5 mV) (Fig. 1C), suggesting that the
CRH response was attenuated by the inhibition of TREK-1 channels.
In all the experiments described
above, the intracellular pH (pHint) was
buffered to pH 7.4 with the whole-cell
pipette solution. Because intracellular
acidification was known to activate
TREK-1 channels (16), we examined
whether lowering the pHint to 7.0 afFIG. 4. The AA-mediated enhancement of the time-invariant outward current was not affected
fected the basal activity of TREK-1 chanby TEA or ETYA. A, After the inhibition of the delayed rectifier by TEA, AA increased the timeinvariant outward current. Current traces evoked from voltage steps (200 msec) to ⫺40, ⫺20, 0,
nels in corticotropes. Figure 8C shows
and 20 mV from a holding potential of ⫺70 mV in control, in TEA (10 mM), and in the presence of
that in cells recorded with a whole-cell
10 M AA ⫹ 10 mM TEA. Note that TEA alone eliminated most of the delayed rectifier evoked at
pipette solution of pH 7.0, the amplitude
positive potentials. In the presence of TEA, AA increased an outward current, which exhibited little
time dependence. B, IV plots of the same cell (as in A) in control, in TEA, or in TEA ⫹ 10 M AA.
of the background TREK-1 current at
Note that in control condition, most of the delayed rectifier evoked at potentials more than or
⫺40 mV was 24 ⫾ 4 pA (n ⫽ 21). This
equal to ⫺20 mV was suppressed by TEA. In the presence of TEA, AA enhanced the timevalue is comparable with the current reinvariant outward current at all potentials examined. C, The AA-mediated enhancement of the
time-invariant outward current did not require AA metabolism. ETYA, an inhibitor of AA
corded from cells with pHint of 7.4 when
metabolism, caused a small reduction in the delayed rectifier but could not prevent the enhancing
stimulated by 5 M AA (30 ⫾ 6 pA; n ⫽
effect of AA on the time-invariant outward current. IV plots of a cell in control, in ETYA (30 M),
26) but much larger than the basal
and in ETYA ⫹ 10 M AA.
TREK-1 current at pHint 7.4 (⫺1.5 ⫾ 0.7
pA; n ⫽ 53). As shown in Fig. 8C, applirent at ⫺70 mV by AA (10 M) was essentially abolished
cation of CRH (20 nM) or fluoxetine (50 M) essentially elimby the application of 8CPT-cAMP (500 M). As shown in
inated the background TREK-1 current in cells with intraFig. 7B, 8CPT-cAMP suppressed the AA-activated current
cellular acidification. The increase in basal TREK-1 current
at a wide range of potential. In seven cells examined,
with intracellular acidification was accompanied by hyper8CPT-cAMP (500 M) reduced the AA-mediated current
polarization. Figure 8D shows that the mean resting potenat ⫺40 mV by 76 ⫾ 7%. Because CRH receptors are coutial in corticotropes with pHint 7.0 (⫺82 ⫾ 2 mV; n ⫽ 22) was
pled to adenylate cyclase, we examined whether the actimore negative (⌬Vm of 34 ⫾ 5 mV) than that recorded from
vation of CRH receptors also modulates the TREK curcells with pHint of 7.4 (⫺48 ⫾ 3 mV; n ⫽ 53) but comparable
rent. Figure 7C shows that the AA-mediated increase in
with corticotropes (with pHint 7.4) that were stimulated with
outward current at ⫺70 mV was strongly suppressed by
AA (Fig. 2). Application of CRH (20 nM) or fluoxetine (50
CRH (20 nM). The IV plot in Fig. 7D shows that CRH
M) caused a similar depolarization in these cells (⌬Vm of
suppressed the AA-mediated current at a wide range of
35 ⫾ 4 mV for CRH and 36 ⫾ 4 mV for fluoxetine) (Fig. 8D).
potentials. On average, CRH (20 nM) suppressed the AAThus, the activity of TREK-1 channel is responsible for setmediated current at ⫺40 mV by 76 ⫾ 7% (n ⫽ 7). Figure
ting the resting potential of corticotropes.
8A shows that CRH also reversed the AA-mediated hyperpolarization. In sixteen cells examined, the AA-mediated hyperpolarization was ⫺38 ⫾ 3 mV, and the application of Discussion
CRH (in the presence of AA) depolarized the cells by 26 ⫾ 3
mV (n ⫽ 12) (Fig. 8B). Thus, in the presence of AA, the AA inhibited the delayed rectifier but increased
CRH-mediated depolarization could only partially restore the TREK-1 current
the potential to the basal values (before AA). Application of
Our results show that in GFP-labeled mouse corticothe TREK-1 channel inhibitor, fluoxetine (50 M), to corti- tropes, exogenous application of AA caused an initial sup-
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FIG. 5. The AA-mediated current was carried primarily by K⫹. A, IV
plots of the AA-mediated current (difference between the current
evoked before and in the presence of 10 M AA) when cells were
bathed in different [K⫹] ([K⫹]o). B, Plot of the reversal potential (Eo) of
the AA-mediated current vs. extracellular [K⫹]. The slope of the linear
regression was 45 mV. Each data point was the average of the reversal
potential obtained from six or 12 cells.

pression and acceleration in the current decay of the delayed rectifier (Fig. 3A). Similar actions of AA on the
delayed rectifier have been described in other cell types,
including the rat pulmonary arterial myocytes (25) and
bovine AZF cells (26). The AA-mediated inhibition of the
delayed rectifier was shown to cause depolarization in
pulmonary arterial myocytes (25). However, there was no
activation of the delayed rectifier near the resting potential
of corticotropes. Instead, the dominant effect of AA in
corticotropes at the resting potential was the activation of
a background current. The shift in the reversal potential of
the AA-activated background current with changes in extracellular [K⫹] (Fig. 5) was similar to that predicted by the
Nernst potential of K⫹, indicating that the AA-activated
current was primarily carried by K⫹. At ⫺40 mV, the
mean increase in membrane current was approximately
100 pA. Because the mean input resistance of corticotrope
is approximately 1.3 G⍀ (Fig. 1C), the large increase in
background K⫹ current by AA near the resting potential
resulted in a strong hyperpolarization (Fig. 2B).
Several lines of evidence indicate that the AA-activated
current in corticotropes is due to an increase in the activities of TREK-1 channels. First, the AA-mediated increase
in current did not require AA metabolism. Similar to that
described in bovine AZF cells (26), inhibition of AA metabolism by ETYA failed to block the AA-mediated acti-

FIG. 6. The AA-activated current involves TREK-1 channels. A,
Application of the TREK-1 channel inhibitor, fluoxetine (50 M),
strongly suppressed the AA-mediated current at a wide range of
potentials. B, The AA-mediated current was also reduced by
chlorpromazine (10 M), an inhibitor of TREK-1 and TREK-2 channels.
C, Application of ruthenium red (10 M), an inhibitor of TRAAK
channels, had only minor inhibitory effect on the current. D, External
acidification (pHext 6.4) caused a partial inhibition of the current. A–D,
Representative IV plots from four different cells when exposed to 10
M AA and subsequently to the various inhibitors (in the continued
presence of AA). E, Summary of the average reduction of AA-mediated
current at ⫺40 mV by fluoxetine (n ⫽ 6), chlorpromazine (n ⫽ 6),
ruthenium red (n ⫽ 8), and pHext 6.4 (n ⫽ 8). F, The effect of
penfluridol and pimozide (2 or 10 M) on the amplitude of AAmediated current at ⫺40 mV. Values in each group were averaged
from three to six cells.

vation of the TREK-1 current in corticotropes (Fig. 4C).
Second, the AA-activated current was strongly suppressed
by pharmacological blockers of TREK channels but not
that of TRAAK channels. We found that the AA-activated
K⫹ current (at ⫺40 mV) in corticotropes was reduced
approximately 80% and approximately 60%, respectively, by fluoxetine (50 M) and chlorpromazine (10 M)
(Fig. 6E). These values closely resembled the reported values of inhibition of human TREK-1 channels by fluoxetine
(19) and human TREK-1 and TREK-2 channels by cholorpromazine (20). Our results ruled out the involvement
of TRAAK channels, because TRAAK channels are insensitive to chlorpromazine (20). Furthermore, ruthenium
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inhibited by penfluridol or pimozide at
10 M (Fig. 6F). However, penfluridol
and pimozide were reported to inhibit
the basal TREK-1 current (without AA)
in bovine AZF cells with IC50 values of
0.19 and 0.35 M, respectively (23).
This discrepancy may be related to the
high concentration of AA (10 M) used
to activate the TREK-1 channels in corticotropes. As shown in Fig. 6F, a 5-fold
lower concentration of pimozide (2
M) was able to largely suppress the
current activated by 2 M AA. Third,
consistent with the activation of TREK
channels by intracellular acidification
(16), the lowering of pHint (from 7.4 to
7.0) dramatically increased the amplitude of the basal current in corticoFIG. 7. The AA-mediated current was negatively regulated by cAMP and CRH. A, The cell
tropes. Fourth, the TREK, but not
permeable cAMP analog, 8CPT-cAMP (0.5 mM), strongly reduced the AA (10 M)-mediated
increase in outward current. The cell was voltage clamped at ⫺70 mV. B, IV plots of the
TRAAK, channels are known to be negcurrent in AA and in AA ⫹ 8CPT-cAMP. Same cell as in A. C, The AA (10 M)-mediated
atively regulated by cAMP-dependent
increase in outward current was strongly suppressed by CRH (20 nM). The cell was voltage
signaling pathways, including protein
clamped at ⫺70 mV. D, IV plots of the current in the presence of AA and in AA ⫹ CRH. Same
cell as in C.
kinase A (27) and the cAMP-activated
guanine nucleotide exchange factorsred, a potent inhibitor of TRAAK channels (21), had only
mediated pathway (28). Consistent with this, the cell pera minor effect on the AA-activated current in corticotropes
meable cAMP analog, 8CPT-cAMP (0.5 mM), strongly
(e.g. Fig. 6C). The AA-activated current was also sensitive
suppressed the AA-activated K⫹ current in corticotropes
to DPBP; the current activated by 10 M AA was largely
(e.g. Fig. 7B). Fifth, among the members of the
TREK family, only the TREK-1 channel exhibits a strong outward rectification due to its sensitivity to extracellular divalent ions (16). Consistent with the involvement of TREK-1
channels, the AA-mediated current in corticotropes in the normal bath solution (containing
Ca2⫹ and Mg2⫹) exhibited outward rectification (Fig. 4B). In corticotropes, the AA-activated current during each voltage step (e.g. at
20 mV) was essentially a square wave that exhibited little time dependence (Fig. 3Aiii). Similarly, the AA-activated TREK-1 current in bovine AZF did not exhibit any time dependence
at 20 mV (26). In contrast, in cells with expressed human (19) or mouse TREK-1 channels (29), the TREK-1 current evoked at positive test potentials (⬎0 mV) comprised an
FIG. 8. Effects of CRH and intracellular acidification on membrane potentials. A,
instantaneous and a sustained component. It is
The AA (10 M)-mediated hyperpolarization was reversed by CRH (20 nM). B,
not clear whether this discrepancy is due to the
Summary of the effects of AA (10 M), CRH (20 nM; in the presence of AA),
difference between native and expressed
fluoxetine (50 M; in the absence of AA), and CRH (20 nM; in the presence of
fluoxetine) on membrane potentials. Values averaged from 10 to 23 cells (pHint 7.4)
TREK-1 channels. Lastly, extracellular acidifor each treatment. C, Intracellular acidification (pHint 7.0) increased the basal
fication (pH 6.4) reduced the AA-activated K⫹
current at ⫺40 mV (n ⫽ 22), and this current could be inhibited by CRH (20 nM; n ⫽
current in corticotropes (Fig. 6E). Extracellular
9) or fluoxetine (50 M; n ⫽ 5). D, Hyperpolarization induced by intracellular
acidification was reported to have inhibitory
acidification and its reversal by CRH or fluoxetine. Same cells as in C.
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action on human TREK-1 channels but enhancing actions
on TREK-2 channels (22). Our observation that approximately 48% of the AA-activated current was inhibited
with pHext 6.4 was similar to that reported for murine
TREK-1 channels (22).
The TREK-1 channels set the resting potential and
were targets of CRH
Our previous study showed that CRH evoked depolarization via a cAMP-dependent closure of a background K⫹
conductance in rat corticotropes, but the identity of the
CRH-sensitive background K⫹ current remains elusive
(2). Here, we show that CRH exerted a similar effect on the
membrane potential of GFP-labeled mouse corticotropes.
The CRH evoked membrane potential depolarization
(Fig. 1C) was accompanied by an increase in cell input
resistance (Fig. 1D), reflecting the closure of a background
conductance. We also found that application of the
TREK-1 channel inhibitor, fluoxetine, to mouse corticotropes caused a similar depolarization (Fig. 8B). Although
fluoxetine was also reported to inhibit the delayed rectifier
(30), there was no significant activation of the delayed
rectifier in corticotropes at potentials less than ⫺20 mV
(Figs. 3 and 4). Thus, the fluoxetine-evoked depolarization in corticotropes is primarily due to the inhibition of
basal activity of TREK-1 channels. This finding suggests
that the resting potential of corticotropes is primarily determined by the basal activity of TREK-1 channels. Consistent with this, an increase in TREK-1 current by intracellular acidification resulted in a strong hyperpolarization that
could be reversed by fluoxetine (Fig. 8D). The activities of
TREK-1 channels are strongly regulated by phosphorylation, and some TREK-1 channels are phosphorylated under
basal condition (16). This may contribute to the variability
of resting potential among corticotropes (ranging from
⫺40 to ⫺50 mV).
Our results also indicate that the CRH-sensitive
background K⫹ current is the TREK-1 current. As
shown in Fig. 8C, the basal TREK-1 current induced by
intracellular acidification was largely abolished by
CRH, resulting in a strong depolarization (Fig. 8D).
CRH also suppressed the TREK-1 current activated by
AA and reversed the AA-mediated hyperpolarization
(Figs. 7C and 8A). In the presence of fluoxetine, CRH
evoked only a small depolarization (⬃11 mV) (Fig. 8B).
Fluoxetine inhibited only approximately 80% of the
TREK-1 current (Fig. 6E); thus, it is possible that the small
depolarization was due to a suppression of the remaining TREK-1 current by CRH. Because the CRH receptor
is coupled to adenylate cyclase, the inhibitory action of
CRH is likely to be mediated via the elevation of cellular
cAMP (Fig. 7, A and B).
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Potential role of AA as a negative feedback
regulator in ACTH release
Upon stimulation with CRH or AVP, AA is generated in
the pituitary gland (4, 5). Because both CRH and AVP trigger
[Ca2⫹]i rise in corticotropes (2, 15), it is likely that the [Ca2⫹]i
elevation activates the Ca2⫹-dependent cytosolic form of
phospholipase A2, which in turn cleaves the membrane phospholipids to generate AA. The concentration of AA near the
corticotropes during CRH stimulation is unclear, but in most
tissues, the concentration of AA is estimated to be at 2–10 M
(7). Note that AA can activate TREK-1 channels from either
side of the plasma membrane (16). It is conceivable that with
a prolonged CRH stimulation (e.g. during a chronic stress),
the concentration of AA near the plasma membrane (inside
or outside) of a corticotrope could reach several micromolar.
In our experiments, 5 or 10 M AA was able to evoke strong
hyperpolarization (Fig. 2B). There was a 3-fold increase in
the amplitude of the TREK-1 current (at ⫺40 mV) in corticotropes when the concentration of AA was increased from
5 to 10 M. A similar increase in TREK-1 current by the same
concentrations of AA had been reported in bovine AZF (26).
Therefore, it is likely that during a prolonged CRH stimulation, the concentration of AA near the plasma membrane
of corticotropes could cause activation of the TREK-1 current and hyperpolarization. This will in turn limit the depolarization evoked by CRH and thus reduce voltage-gated
Ca2⫹ channels activation and ACTH release. Interestingly, a
previous study has shown that AA at high concentration
(100 M) increased basal ACTH release but had no effect on
the CRH-stimulated ACTH secretion from rat pituitary cells
(4). We found that when corticotropes were exposed to high
concentrations of AA (e.g. 30 M), the patch clamp recording
became unstable (possibly due to changes in membrane fluidity), and there was an increase in the leakage of extracellular Ca2⫹ into the cell (Lee, A. K. and A. Tse, unpublished
observations). Thus, it is possible that with very high concentrations of AA, the increase in extracellular Ca2⫹ leak into
corticotropes in turn triggers ACTH release. Such effect may
offset the inhibitory action of AA on the electrical excitability
of the corticotropes. Overall, our result raises the possibility
that AA at physiological concentrations (5 to 10 M) may act
as a negative regulator of ACTH release. We suggest that
other than the negative feedback action of glucocorticoids,
the activation of TREK-1 channels in corticotropes by AA
may provide an additional protective mechanism to prevent
excessive ACTH release during chronic stress.
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